Peer Review History
| Original SubmissionNovember 22, 2020 |
|---|
|
PONE-D-20-36803 Significance of information obtained during transanal drainage tube placement after anterior resection of colorectal cancer PLOS ONE Dear Dr. Shibutani, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. However generally well written, clinically important subject, it needs major revision before publication. Please submit your revised manuscript by 15th of March. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Emre Bozkurt Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your ethics statement in the manuscript and in the online submission form, please ensure that you have discussed whether all data/samples were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data/samples from their medical records used in research, please include this information. 3. In the ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records/samples used in your retrospective study, including the date range (month and year) during which patients' medical records/samples were accessed. Comments to the Author Reviewer #1: Dear Author. Thanks for your article and precious work. I have some concerns about the methods using for measuring the fecal volume. I dont think if it is possible all fecal volume is passing through tdt. And also in some major studies and metaanalyses fecal volume is not one of the major risk factors. Splenic flexura mobilization, tension free anastamosis with a good blood supply must be the main purposes for a good anastomosis. Reviewer #2: Page 7, line 4 Comment: 51 patients in 3 years means a low volume for colorectal surgery which is a risk factor for anastomotic leakage. Page 8, line 9: Did you have the data for the first gas passing in the postoperative period? If yes do you think adding this information may add value to your study? Page 10, Line 6: 3 patients who had open surgery should be excluded from the study in order to perform a unique evaluation and a more proper statistal analyses. Page 11, Line 3: What was the preoperative grade of the tumors for the patients? Especially for the LAR group, why did not patients receieved neo-adjuvant chemo-radio therapy? Table 2: LAR known to be more risky for the anastomotıc leakage. Why the high anterior group had more anastomotic leakage when compared to LAR? Page 22, line 15: The authors should explain other possible rısk factors. Watery diarrhea should not be the only factor that is emphasized repeatedly. Page 23, Line 8: Authors should add a paragraph about the relation between BMI and anastomotic leakage to the discussion which is emphasized at the patients characteristics section. Reviewer #3: MAJOR REVISION The article describes a technically sound scientific research that will benefit in clinical practice. The manuscript is easy to understand and written in standard English. However, the results are not appropriately drawn based on the data presented. The results of the study was not strongly defended in the discussion. Therefore, my additional recommendations are below: 1. It is unclear how and where (operating room?, postoperatively in the clinic?, colonoscopically?) the pleats drain was inserted. It should be mentioned in more detail in the patients and methods section. 2. In this study, it was stated that TDT is effective in preventing anastomotic leakage. But, it would be more effective to compare the TDT group with a control group without TDT to asses whether it is effectual or not in preventing the leakage. 3. In the study, a single dependent group that received TDT for all cases was analyzed. However, analyzed subgroups do not have the clear definitons in the patients and methods section. 4. It was stated that cases were diveded into “high” and “low” subgroups according to tumor diameters estimated 35 mm cut-off value by the ROC analysis in the results section. Firstly, before calculating the cut-off value and creating subgroups, the relationship between tumor diameter and anastomotic leakage should be demonstrated by correlation tests. If a significant association between them was found, it would be more robust to give the cut-off value by ROC analysis. 5. In the present study involving a single dependent group, patients were divided into the other two subgroups as “high” and “low” according to cut-off value for the fecal volume drained from the TDT, and thus patients were distinguished according to the presence of anastomotic leakage. What should be done before determining a cut-off value and creating subgroups is to demonstrate a significant association between fecal volume and anastomotic leakage by using correlation tests. 6. Table 2 shows the preoperative factors associated with anastomotic leakage. What is the statistical method used here? Were preoperative parameters just compared? Or did multiple factors that may affect anastomotic leakage as the dependent variable analyze? 7. There seems to be a comparison of the anastomotic leakage with different defecation statuses in table 4, which is difficult to understand. According the table 4, why is the total number of patients without fecal incontinence (46 cases) not equal to the total number of patients with intentional defecation (11 cases)? 8. How many of patients had major and minor anastomotic leakage? What is the re-operation rate due to leakage? 9. All patients had the standard mechanical bowel preparation on the day before surgery. So, when did the first defecation postoperatively occur? 10. Leakage was reported in the other 4 of 51 patients after TDT was removed. However, there are again 47 patients in table 6. Where are the remaining 4 patients? 11. The discussion section has generally superficial content. The results of the study were not sufficiently interpreted and discussed. Especially, the association between tumor diameter and fecal volume and its mechanism lack the support of the literature. Therefore, the discussion section should be revised. While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Significance of information obtained during transanal drainage tube placement after anterior resection of colorectal cancer PONE-D-20-36803R1 Dear Dr. Shibutani, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Zubing Mei, MD,PH.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-20-36803R1 Significance of information obtained during transanal drainage tube placement after anterior resection of colorectal cancer Dear Dr. Shibutani: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Zubing Mei Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .